These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38956809)

  • 1. Vincristine exposure in Kenyan children with cancer: CHAPATI feasibility study.
    Uittenboogaard A; van de Velde M; van de Heijden L; Mukuhi L; de Vries N; Langat S; Olbara G; Huitema ADR; Vik T; Kaspers G; Njuguna F
    Pediatr Blood Cancer; 2024 Sep; 71(9):e31160. PubMed ID: 38956809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer.
    Skiles JL; Chiang C; Li CH; Martin S; Smith EL; Olbara G; Jones DR; Vik TA; Mostert S; Abbink F; Kaspers GJ; Li L; Njuguna F; Sajdyk TJ; Renbarger JL
    Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vincristine-induced peripheral neuropathy in children with cancer: A systematic review.
    van de Velde ME; Kaspers GL; Abbink FCH; Wilhelm AJ; Ket JCF; van den Berg MH
    Crit Rev Oncol Hematol; 2017 Jun; 114():114-130. PubMed ID: 28477739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
    Lavoie Smith EM; Li L; Chiang C; Thomas K; Hutchinson RJ; Wells EM; Ho RH; Skiles J; Chakraborty A; Bridges CM; Renbarger J
    J Peripher Nerv Syst; 2015 Mar; 20(1):37-46. PubMed ID: 25977177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
    Lavoie Smith EM; Li L; Hutchinson RJ; Ho R; Burnette WB; Wells E; Bridges C; Renbarger J
    Cancer Nurs; 2013; 36(5):E49-60. PubMed ID: 23842524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity as a Potential Risk Factor for Vincristine-induced Peripheral Neuropathy.
    Sajdyk TJ; Boyle FA; Foran KS; Tong Y; Pandya P; Smith EML; Ho RH; Wells E; Renbarger JL
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e637-e640. PubMed ID: 31634238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
    Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring vincristine-induced peripheral neuropathy in children with cancer: validation of the Dutch pediatric-modified Total Neuropathy Score.
    Schouten SM; van de Velde ME; Kaspers GJL; Mokkink LB; van der Sluis IM; van den Bos C; Hartman A; Abbink FCH; van den Berg MH
    Support Care Cancer; 2020 Jun; 28(6):2867-2873. PubMed ID: 31732853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A cohort study of vincristine-induced peripheral neuropathy in children].
    Li C; Jin J; Huang J; Yang XY; Li Y; Yan YY; Yang C
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 May; 25(5):470-475. PubMed ID: 37272172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia.
    Li T; Kandula T; Cohn RJ; Kiernan MC; Park SB; Farrar MA
    Clin Neurophysiol; 2023 Oct; 154():157-168. PubMed ID: 37633123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis.
    Centanni M; van de Velde ME; Uittenboogaard A; Kaspers GJL; Karlsson MO; Friberg LE
    Clin Pharmacokinet; 2024 Feb; 63(2):197-209. PubMed ID: 38141094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia.
    Li L; Sajdyk T; Smith EML; Chang CW; Li C; Ho RH; Hutchinson R; Wells E; Skiles JL; Winick N; Martin PL; Renbarger JL
    Clin Pharmacol Ther; 2019 Jun; 105(6):1421-1428. PubMed ID: 30506673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial on the effect of 1-hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis).
    Uittenboogaard A; van den Berg MH; Abbink FCH; Twisk JWR; van der Sluis IM; van den Bos C; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; Kaspers GJL; van de Velde ME
    Cancer Med; 2023 Oct; 12(19):19480-19490. PubMed ID: 37732486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
    Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE
    JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RISK FACTORS OF VINCRISTINE-INDUCED PERIPHERAL NEUROPATHY IN ACUTE LYMPHOBLASTIC LEUKAEMIA CHILDREN.
    Tunjungsari DA; Gunawan PI; Ugrasena IDG
    J Med Invest; 2021; 68(3.4):232-237. PubMed ID: 34759136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision Medicine in Childhood Cancer: The Influence of Genetic Polymorphisms on Vincristine-Induced Peripheral Neuropathy.
    Marangoni-Iglecias L; Rojo-Tolosa S; Márquez-Pete N; Cura Y; Moreno-Toro N; Membrive-Jiménez C; Sánchez-Martin A; Pérez-Ramírez C; Jiménez-Morales A
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic factors influencing the development of vincristine-induced neurotoxicity.
    Pozzi E; Fumagalli G; Chiorazzi A; Canta A; Cavaletti G
    Expert Opin Drug Metab Toxicol; 2021 Feb; 17(2):215-226. PubMed ID: 33283553
    [No Abstract]   [Full Text] [Related]  

  • 18. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Chauvenet AR; Shashi V; Selsky C; Morgan E; Kurtzberg J; Bell B;
    J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vincristine-induced peripheral neuropathy: A mini-review.
    Li GZ; Hu YH; Li DY; Zhang Y; Guo HL; Li YM; Chen F; Xu J
    Neurotoxicology; 2020 Dec; 81():161-171. PubMed ID: 33053366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment Tools for Peripheral Neuropathy in Pediatric Oncology: A Systematic Review From the Children's Oncology Group.
    Smolik S; Arland L; Hensley MA; Schissel D; Shepperd B; Thomas K; Rodgers C
    J Pediatr Oncol Nurs; 2018; 35(4):267-275. PubMed ID: 29566596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.